Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Oral Oncol. 2013 Jul 23;49(9):893–902. doi: 10.1016/j.oraloncology.2013.06.011

Figure 5. Response of patient tumor-derived HNSCC xenografts to combined VDA-chemotherapy.

Figure 5

Hematoxylin and eosin stained sections of patient tumor-derived HNSCC xenografts 24 hours post treatment with VDA alone (25 mg/kg, i.p.) or in combination with chemotherapy (Docetaxel, 10 mg/kg, i.p.). Images shown are at 10x magnification. Extensive necrosis was seen following combination treatment compared to VDA alone or chemotherapy alone.